Correction
Accepted on 17 Apr 2025
Corrigendum: Liposomes have a direct effect on multiple myeloma: A Mendelian randomization study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1603501
Type at least 3 characters
1,822 articles
Review
Accepted on 17 Apr 2025
The biology of Chronic Myeloid Leukemia: an overview of the new insights and biomarkers
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1546813
Original Research
Accepted on 15 Apr 2025
Impact of Secondary Hematologic Malignancies on Prognosis of Hodgkin’s Lymphoma Survivors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1566063
Original Research
Accepted on 14 Apr 2025
CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1569707
- 125 views
Systematic Review
Published on 14 Apr 2025
Atopic dermatitis and lymphoma risk: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1580550
- 419 views
Original Research
Accepted on 11 Apr 2025
Analysis of Pharmacotherapeutic Approaches for Multiple Myeloma and Correlated Renal and Pulmonary Impairments: A Retrospective Real-World Registry Study in the Greater Gulf Region (REPAIR Study)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1547138
- 281 views
Case Report
Accepted on 09 Apr 2025
Venetoclax combined with ATRA shows promising therapeutic potential for TFG::RARA variant APL：a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1529640
Case Report
Published on 09 Apr 2025
CD20-positive peripheral T-cell lymphoma not otherwise specified: a case series and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1553969
- 314 views
Review
Accepted on 07 Apr 2025
Preventing Pneumococcal Infections in Patients With Hematological Malignancies: A Review of Evidence and Recommendations Based on Modified Delphi Consensus
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1546641
- 114 views
Original Research
Published on 07 Apr 2025
Artificial intelligence-assisted early screening of acute promyelocytic leukaemia in blood smears: a prospective evaluation of MC-100i
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1572838
- 474 views
Case Report
Published on 07 Apr 2025
Case Report: Radiological characteristics and pathological correlation analysis of extranodal Rosai-Dorfman disease of liver
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1484820
- 269 views
Review
Accepted on 03 Apr 2025
A potential prognostic marker for hematologic neoplasms: CD58
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586842
Case Report
Accepted on 03 Apr 2025
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a Patient with Pre-existing Essential Thrombocythemia: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1573893
Perspective
Published on 01 Apr 2025
Total skin electron beam therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1498855
- 421 views
Case Report
Published on 01 Apr 2025
18F-FDG PET/CT in the diagnosis and treatment of atypical extensive skin lesions in extranodal natural killer/T-cell lymphoma, nasal type: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1480661
- 323 views
Review
Accepted on 31 Mar 2025
Targeting BCL2 in Waldenström Macroglobulinemia: From biology to treatment management
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1564869
- 139 views